関連する実験動画
Updated: Jul 19, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
まとめ
ヘパリンナトリウム療法は,特に女性,重症患者,アスピリンを服用している患者において,出血を引き起こす可能性があります. 重度のアルコールの使用は,ヘパリニゼーション中に大きな出血のリスクを高めます.
科学分野:
- 薬理学 薬理学とは
- クリニカル・メディシン 臨床医学
- 患者の安全性についてです.
背景:
- ヘパリンナトリウムは,広く使用されている抗凝固剤です.
- ヘパリン治療に伴う出血リスクを理解することは,患者の安全にとって極めて重要です.
- 患者特有の危険因子を特定することで,ヘパリン治療プロトコルを改善することができます.
研究 の 目的:
- ヘパリンナトリウム療法中の出血の発生率とリスク要因を調査する.
- 大型出血事件と小型の出血事件に関連した要因を区別するために.
- 累積的なリスクと出血エピソードのタイミングを評価する.
主な方法:
- ヘパリンナトリウムを投与した2,656人の患者の遡及的分析.
- 患者の人口統計,併発症,併用薬の特定.
- 投与量による効果とリスク因子関連を特定するための統計分析.
主要な成果:
- ヘパリン療法中の出血は,投与量に関係しており,女性や重症患者ではより一般的です.
- アスピリンの同時使用と重度のアルコールの消費は,出血のリスク,特に重度の出血を大幅に増加させます.
- 血液出血の7日間の累積リスクは9.1%で,ヘパリン投与の3日目に最も高いリスクが観察されました.
結論:
- ヘパリンナトリウム療法では,特に高リスク患者群では,出血を注意深くモニタリングする必要があります.
- 投与量を調整し,アスピリンまたは重度のアルコール飲料を飲む人との併用投与を慎重に行うことをお勧めします.
- 出血のリスク要因を早期に認識することで,抗凝固薬の投与中に起こる有害事象を軽減することができます.
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...